MNX.V - Manitex Capital Inc.
| Previous Close | 0.1400 |
| Open | 0.1400 |
| Bid | 0.1600 x 0 |
| Ask | 0.2500 x 0 |
| Day's Range | 0.1400 - 0.1400 |
| 52 Week Range | 0.1400 - 0.3900 |
| Volume | 5,000 |
| Avg. Volume | 79 |
| Market Cap | 1.759M |
| Beta (3Y Monthly) | 1.86 |
| PE Ratio (TTM) | 0.22 |
| EPS (TTM) | 0.6260 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Early Warning Report Filed Pursuant To National Instrument 62-103
KIRKLAND, QC, Oct. 10, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") announces that it has acquired convertible debenture units ("Units") of Ortho Regenerative Technologies Inc. ("Ortho RTI") in consideration of the conversion of loans that were owed by Ortho RTI in its favor for an aggregate principal amount of $894,000. Each Unit consists of one 10% unsecured convertible debenture for a principal amount of $1,000 (each, a "Debenture") convertible at a $0.30 price per Class "A" share of Ortho RTI ("Common Share") and 2,000 Common Share purchase warrants (each, a "Warrant"), with an exercise price of $0.50 ("Exercise Price"), representing a 60% warrant coverage.
- CNW Group
Manitex Capital Inc. Completes Distribution of Dividend-In-Kind Consisting of Warrants of Valeo Pharma Inc.
KIRKLAND, QC, Aug. 28, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") is pleased to announce that it has completed the distribution to its shareholders of its previously announced special dividend-in-kind (the "Dividend") of share purchase warrants of Valeo Pharma Inc., ("Valeo Warrants") held by Manitex. The Dividend has a deemed price of $0.065 per Valeo Warrant and was distributed today to holders of record of common shares of Manitex ("Manitex Shares") at the close of business on August 9, 2019 (the "Record Date"), on a pro rata basis of 0.1 Valeo Warrant per Manitex Share.
- CNW Group
Manitex Capital Inc. declares a dividend-in-kind of warrants of Valeo Pharma Inc.
KIRKLAND, QC, July 30, 2019 /CNW Telbec/ - Manitex Capital Inc. (TSXV:MNX.V - News), ("Manitex"), is pleased to announce that its Board of Directors has declared a special dividend-in-kind (the "Dividend") of 1,256,127 share purchase warrants of Valeo Pharma Inc. (the "Valeo Warrants") held by Manitex. The Dividend shall have a deemed price per Valeo Warrant based on the closing price of the Valeo Warrants (VPH.WT) on the Canadian Securities Exchange (the "CSE") on the trading day prior to payment of the Dividend, expected to occur on or about August 28, 2019, to holders of record of common shares of Manitex (the "Manitex Shares") at the close of business on August 9, 2019 (the "Record Date"). Based upon the number of Manitex Shares currently outstanding, and ignoring the effect of rounding for fractional interests, one Valeo Warrant will be paid under the Dividend for every 10 (ten) Manitex Shares (or 0.1 Valeo Warrants per Manitex Share) held on the Record Date.
- Simply Wall St.
Do Insiders Own Lots Of Shares In Manitex Capital Inc. (CVE:MNX)?
If you want to know who really controls Manitex Capital Inc. (CVE:MNX), then you'll have to look at the makeup of its...
- CNW Group
Manitex Capital Inc. announces results of AGM
KIRKLAND, QC, April 5, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex" or the "Company") is pleased to announce the voting results from its Annual General and Special Meeting of shareholders (the "Meeting") held today in Kirkland, Quebec. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 8,017,627 representing 63.83% of the Company's issued and outstanding shares.
- Simply Wall St.
Introducing Manitex Capital (CVE:MNX), The Stock That Zoomed 105% In The Last Five Years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you can make far more than 100%Read More...
- CNW Group
Manitex Capital Inc.'s affiliate, Valeo Pharma Inc., announces approval of Onstryv® (safinamide) for Canada
KIRKLAND, QC, Jan. 15, 2019 /CNW Telbec/ - Manitex Capital Inc. (TSXV:MNX.V - News) announces that its affiliate, Valeo Pharma Inc., has received approval from Health Canada for a new Parkinson's Disease product ONSTRY® (safinamide) in Canada. Valeo Pharma plans to launch ONSTRYV® in Canada in the first half of 2019.
- CNW Group
Manitex Capital Inc. declares a dividend-in-kind of shares of Valeo Pharma Inc.
KIRKLAND, QC, Jan. 11, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") is pleased to announce that its board of directors has declared a special dividend-in-kind (the "Dividend") of 1,256,127 common shares of Valeo Pharma Inc., ("Valeo") held by Manitex. The Dividend has a deemed price of $0.40 per Valeo Share and is payable on, or about, February 1, 2019 to holders of record of common shares of Manitex ("Manitex Shares") at the close of business on January 22, 2019 (the "Record Date").
